icon-folder.gif   Conference Reports for NATAP  
 
  EASL 2024
June 5-8, Milan, Italy 		Back grey_arrow_rt.gif
 
 
 
Tirzepatide for the treatment of metabolic dysfunction-associated
steatohepatitis with liver fibrosis: results of the SYNERGY-NASH phase 2 trial
 
 
  EASL 2024 June 5-8 Milan Italy
 

 
Published paper attached
 
Rohit Loomba
San Diego UCSD
 
Late Breaker

0611241

0611242

0611243

0611244

0611245

0611246

0611247

0611248